Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway.

@article{Min2010AlphalipoicAI,
  title={Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway.},
  author={Ae-Kyung Min and Mi-kyung Kim and Hye-Young Seo and Hye-Soon Kim and Byoung Kuk Jang and Jae Seok Hwang and Hueng-Sik Choi and Ki-Up Lee and Keun Gyu Park and In-kyu Lee},
  journal={Biochemical and biophysical research communications},
  year={2010},
  volume={393 3},
  pages={
          536-41
        }
}

Figures from this paper

Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways.
TLDR
It was shown that ALA reduced significantly the TGF-β1 and p-Smad3 protein expressions in the BLM + ALA group and did not exhibit any significant effect on the p38 mitogen-activated kinase (MAPK) activation induced by BLM.
The potential antifibrotic impact of apocynin and alpha-lipoic acid in concanavalin A-induced liver fibrosis in rats: Role of NADPH oxidases 1 and 4.
TLDR
Findings indicate that using apocynin and α-LA in combination possess marked antifibrotic effects, and that NOX enzymes are partially involved in the pathogenesis of ConA-induced liver fibrosis.
Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats
TLDR
Results show that α-LA might be compelling at forestalling collagen deposition and hepatic oxidative stress as well as downregulating the expression of hepatic proinflammatory cytokines, iNOS, and NF-κB and upregulating MMP-13 expression.
Alpha-lipoic acid inhibits peridural fibrosis following laminectomy through the inactivation of TGF-β1, PDGF, PAI-1 and IL-6 expressions.
TLDR
Investigation of parenteral administration of alpha-lipoic acid in laminectomized rabbits found that intramuscular administration of ALA is a promising treatment for the prevention of peridural fibrosis in the postoperative period.
Protective effects of curcumin, α-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats
TLDR
Curcumin, α-lipoic acid, and N-acetylcysteine protect rats against CCl4-induced liver fibrosis most possibly through their antioxidant activities and their capacities to induce MMP-13 and to inhibit TGF-α levels.
Antioxidative and Immunomodulatory Effects of A-Lipoic Acid in Rat Colitis Model Induced by Acetic Acid
TLDR
AlA may possibly have some therapeutic usefulness in the management of ulcerative colitis and could significantly decrease the of colonic tissue with AA-induced colitis.
...
...

References

SHOWING 1-10 OF 41 REFERENCES
Critical Role of Plasminogen Activator Inhibitor-1 in Cholestatic Liver Injury and Fibrosis
TLDR
The data suggest that PAI-1 plays a causal role in mediating fibrosis during cholestasis and that early liver injury and inflammation due to bile duct ligation was significantly blunted in PAi-1-/- mice in comparison with wild-type mice.
Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.
TLDR
It is suggested that GSH inhibits TGF-beta-stimulated PAI-1 expression in fibroblasts by blocking the JNK/p38 pathway, probably by reducing ROS, which leads to an inhibition of the binding of transcription factors to the AP-1, SP- 1, and Smad cis elements in the PAi-1 promoter.
Roles of TGF-beta in hepatic fibrosis.
TLDR
The ubiquitous pathophysiologic relevance of TGF-beta suggests its measurement in blood as a diagnostic tool and the importance of cross-talk among different signaling pathways to either specify, enhance, or inhibit T GF-beta responses.
Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
TLDR
It is concluded that increased TIMP-1 and TIMp-2 expression by HSC plays an important role in the pathogenesis of liver fibrosis and may represent an important therapeutic target in the design of anti-fibrotic strategies for chronic liver disease.
α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase
TLDR
Reduced AMPK activation may play an important role in the genesis of endothelial dysfunction in obese rats and ALA improves vascular dysfunction by normalizing lipid metabolism and activating AMPK in endothelial cells.
Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine‐treated rats
TLDR
It is suggested that anti–TGF‐β intervention should be therapeutic in already‐established fibrotic livers, not only by suppressing fibrosis, but by facilitating hepatocyte regeneration.
Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
TLDR
The recent data indicate that transcriptional regulation of TIMP‐1 gene expression in HSC is mediated via a mechanism which differs considerably from that previously identified in skin fibroblasts, which may represent an important therapeutic target in the design of anti‐fibrotic strategies for chronic liver disease.
Regulation of Hepatic Fibrosis and Extracellular Matrix Genes by the Th Response: New Insight into the Role of Tissue Inhibitors of Matrix Metalloproteinases
TLDR
It is demonstrated that TIMP-1/TIMP-2 play no essential role in fibrogenesis in schistosomiasis, and inhibiting profibrotic cytokines or specific MMP may be a more effective strategy to ameliorate fibrotic pathology.
...
...